Reduced expression of MYC increases longevity and enhances healthspan.
Reduced expression of MYC increases longevity and enhances healthspan.
复制标题
DOI:
10.1016/j.cell.2014.12.016
复制
发表时间:
2015-01-29
期刊:
影响因子:
64.5
通讯作者:
Sedivy JM
中科院分区:
文献类型:
--
作者:
Hofmann JW;Zhao X;De Cecco M;Peterson AL;Pagliaroli L;Manivannan J;Hubbard GB;Ikeno Y;Zhang Y;Feng B;Li X;Serre T;Qi W;Van Remmen H;Miller RA;Bath KG;de Cabo R;Xu H;Neretti N;Sedivy JM
MYC is a highly pleiotropic transcription factor whose deregulation promotes cancer. In contrast, we find that Myc haploinsufficient (Myc+/−) mice exhibit increased lifespan. They show resistance to several age-associated pathologies, including osteoporosis, cardiac fibrosis and immunosenescence. They also appear to be more active, with a higher metabolic rate and healthier lipid metabolism. Transcriptomic analysis reveals a gene expression signature enriched for metabolic and immune processes. The ancestral role of MYC as a regulator of ribosome biogenesis is reflected in reduced protein translation, which is inversely correlated with longevity. We also observe changes in nutrient and energy sensing pathways, including reduced serum IGF-1, increased AMPK activity, and decreased AKT, TOR and S6K activities. In contrast to observations in other longevity models, Myc+/− mice do not show improvements in stress management pathways. Our findings indicate that MYC activity has a significant impact on longevity and multiple aspects of mammalian healthspan.